Social Prescribing and Mental Health: Where Can Community Support Add Value, and When Is Clinical Care Essential?

EVIDENCE & EVALUATION

9/25/202617 min read

Social Prescribing and Mental Health: Where Can Community Support Add Value, and When Is Clinical Care Essential?

Mental health is shaped by much more than symptoms or diagnoses. Relationships, housing, employment, financial stress, discrimination, physical health, caregiving responsibilities, loneliness, purpose and opportunities to participate in community life can all influence how someone feels and functions.

This is one reason social prescribing has attracted growing interest in mental health. A person may be receiving appropriate healthcare but remain isolated, inactive, financially stressed or disconnected from activities that once gave life structure and meaning. Another may be experiencing distress closely related to bereavement, unemployment, caregiving pressure or loss of social connection. In situations like these, community support can add something that clinical care alone may not provide.

But mental health is also an area where the limits of social prescribing need to be particularly clear. Depression, bipolar disorder, psychosis, substance-related conditions, severe anxiety and other mental disorders may require professional assessment, evidence-based psychological treatment, medication, crisis intervention or other clinical care. Social prescribing does not replace those responsibilities.

The most useful question is therefore not whether a person's needs are “clinical” or “social.” In real life, they are often both. A better question is: what support does this person need now, what can safely and meaningfully be provided through community connection, and when must professional mental health or medical care remain central?

This distinction is consistent with the World Health Organization's current approach. WHO describes mental health as existing on a continuum shaped by individual, family, community and structural factors, while emphasizing that effective treatment is available for mental disorders and that people may also need support with relationships, education, employment, housing and meaningful participation.[1,2] WHO's mental health fact sheets were updated on 11 September 2026 and continue to emphasize both the social determinants of mental health and the importance of access to effective care.

Key Points
  • Mental health is influenced by social, economic, relational and community factors as well as psychological and biological factors.

  • Social prescribing may add value when needs include isolation, loss of routine or purpose, reduced activity, practical difficulties, social disconnection or barriers to participation.

  • Community support can complement clinical care for people living with mental disorders, particularly when it supports recovery, relationships, meaningful activity and social inclusion.

  • Current evidence suggests possible benefits for some outcomes, including depressive symptoms, well-being and social outcomes, but effects are heterogeneous and high-certainty evidence remains limited.

  • Social prescribing should not itself be presented as a treatment for a specific mental disorder. Where a pathway connects someone with an evidence-based therapeutic intervention, that intervention should be described and governed according to its own evidence and professional requirements.

  • Suicidal thoughts or behaviour require appropriate professional assessment. Immediate danger, recent serious self-harm, acute psychosis, mania, severe agitation or other major safety concerns may require urgent or emergency care.

  • Community organizations and volunteers should know the limits of their role and have a clear pathway for escalation when a person's needs exceed what they can safely provide.

  • Viet Nam should develop any mental health-related social prescribing pathway alongside, not instead of, mental healthcare, primary healthcare, social work, rehabilitation and social assistance.

  • Mental health and other health information are sensitive personal data. Structured pathways need clear purpose, appropriate information sharing and compliance with Vietnamese personal data protection requirements.

Mental health is broader than mental illness

Mental health and mental disorder are not interchangeable concepts. WHO defines mental health as a state of mental well-being that enables people to cope with the stresses of life, realize their abilities, learn and work well and contribute to their community. Mental health exists on a continuum and can change over time as individual circumstances and wider social and structural conditions change.[1]

A mental disorder, by contrast, is characterized by a clinically significant disturbance in cognition, emotional regulation or behaviour and is usually associated with distress or impairment in important areas of functioning.[2] Someone can therefore experience loneliness, grief, stress or reduced well-being without necessarily having a mental disorder. Conversely, a person living with a diagnosed mental disorder may be clinically stable and still need friendship, employment, education, physical activity, creativity or opportunities to contribute to community life.

This distinction matters because not every difficult emotion should automatically become a medical diagnosis, but clinically important symptoms should not be reframed as merely a social problem simply because social circumstances are involved.

Someone experiencing grief after bereavement may benefit from a supportive community connection without requiring psychiatric treatment. Another person with persistent low mood, severe functional deterioration, hopelessness and suicidal thinking requires professional assessment and potentially treatment. A safe social prescribing pathway needs to recognize both situations rather than forcing everyone into the same model.

Where can community support add value?

Community support may be particularly useful when mental well-being is affected by social disconnection, loss of routine, low confidence, inactivity, practical difficulties or loss of meaningful roles.

Someone who has stopped working because of illness may lose not only income but also relationships, identity and daily structure. A caregiver may spend most of their time supporting someone else and gradually become isolated. A person recovering from depression may be responding to treatment but still have no meaningful activity outside the home. Another person may be distressed partly because housing, debt or employment problems remain unresolved.

A social prescribing pathway might help connect someone with physical activity, arts and cultural activities, volunteering, peer or community groups, learning, skills development or practical forms of support. The aim should not simply be to keep someone occupied. A useful connection should relate to something the person values and be realistic in their circumstances.

Different resources can contribute in different ways. A walking group may combine physical activity, routine and social contact. Creative activities may provide expression and identity. Volunteering can restore a sense of contribution. Learning can rebuild confidence after illness or unemployment. Practical advice can help someone address financial, employment or other social problems that are contributing to distress.

Some of these destinations are ordinary community resources. Others, such as formal social work, welfare advice, psychosocial rehabilitation or professional peer-support services, may themselves have defined professional or organizational responsibilities. Social prescribing can help people navigate toward appropriate support, but it should not blur the roles of the services to which people are connected.

WHO's mental health policy guidance increasingly takes this wider view. Its 2021 community mental health guidance and 2025 mental health policy guidance emphasize person-centered, rights-based and recovery-oriented services, social inclusion, links with housing and employment, action on social and structural determinants and meaningful participation of people with lived experience.[6,7]

What does the evidence actually show?

The evidence is encouraging in some areas, but much less definitive than promotional descriptions of social prescribing sometimes suggest.

A major peer-reviewed umbrella review published on 18 September 2026 synthesized 31 systematic reviews and meta-analyses published between 2010 and December 2024. Among general adult populations, many reviews reported small to moderate improvements in depressive and anxiety symptoms, subjective well-being, social connectedness and physical activity. Benefits were reported more consistently in person-centered, community-based and multi-component approaches, including some group-based programs and models involving link-worker support.[3]

However, the picture became less certain when study quality was taken into account. Among people with diagnosed mental disorders, findings were more variable and were often based on weaker pre-post or non-randomized designs. Across the evidence base, randomized studies with credible active comparators tended to produce smaller or null effects. The authors concluded that high-level evidence for any single social prescribing intervention category remained scarce and that no category had high-certainty evidence of sustained effectiveness.[3]

A 2025 systematic review focused more specifically on social prescribing referral pathways for mental health, psychosocial outcomes and well-being. It included 30 studies covering 27 interventions and identified referral pathways across healthcare, community, social and voluntary sectors. Quantitative findings for well-being, anxiety, depression and quality of life were mixed, while qualitative findings frequently described increased belonging, purpose and social interaction. The authors concluded that substantial heterogeneity in interventions and study methods limited firm conclusions about effectiveness.[4]

Randomized evidence offers another useful perspective. A systematic review and meta-analysis posted as a preprint on 3 August 2026 included 33 randomized trials involving 13,714 adults. It found a modest reduction in depressive symptoms across seven trials involving 1,087 participants and modest improvements in quality of life and physical activity, but no clear overall benefit for anxiety, loneliness or social isolation. Forty percent of the trials were judged to be at high risk of bias.[5]

Two qualifications are important. First, this analysis remains a preprint and has not yet completed peer review. Second, it examined adult social prescribing trials across a broad range of populations and health conditions rather than trials conducted only among people with diagnosed mental disorders. Its mental health results should therefore be interpreted as evidence about mental health outcomes within the broader social prescribing literature, not as a mental-health-specific treatment effect.

Taken together, the evidence does not support saying that social prescribing “treats mental illness.” A more defensible conclusion is that some forms of facilitated community connection may improve selected mental health, well-being and psychosocial outcomes for some people, but effects depend on who receives the intervention, what they are connected to, how the connection is supported and the context in which it takes place.

Mental health recovery also cannot always be reduced to symptom scores. Someone may continue to experience some symptoms but return to work, reconnect with friends, begin volunteering, regain confidence or recover a sense of direction. These outcomes can be highly meaningful, particularly for people living with longer-term mental health conditions.

That does not mean evaluation should become vague. If a program aims to improve depressive symptoms, those symptoms should be measured appropriately. If its goal is participation, belonging or quality of life, those outcomes should be measured instead. Attendance at an activity should never automatically be interpreted as evidence that mental health has improved.

Community support can complement treatment, but clinical care must remain available

The choice does not need to be between medication or psychotherapy on one side and community support on the other.

A person receiving treatment for depression might also benefit from volunteering or a physical activity group. Someone living with schizophrenia may need continuing psychiatric care and medication while also wanting support to return to study, find work or rebuild social relationships. A person recovering from a period of severe anxiety may benefit from both psychological treatment and gradual re-engagement with community life.

WHO's community mental health guidance supports networks that combine clinical and psychosocial responses and recognizes the importance of social inclusion, peer support, supported living and links with other parts of everyday life.[6] Social prescribing may sit alongside such systems as a linking mechanism, especially when a person's goal involves an ordinary community resource rather than another clinical service.

The distinction between these services still matters. Formal peer support delivered within a mental health service, psychosocial rehabilitation, psychological treatment and a social prescribing connection with an ordinary community group are not interchangeable. They may complement one another, but they involve different competencies, governance arrangements and levels of responsibility.

Clinical assessment becomes important when symptoms are persistent, worsening or substantially affecting functioning, or when diagnosis, psychological treatment, medication or another clinical decision may be required. An ordinary community worker or social prescribing link function should not be expected to diagnose major depressive disorder, bipolar disorder, psychosis, post-traumatic stress disorder or another mental disorder.

Some situations warrant particularly prompt assessment. Suicidal thoughts or behaviour require professional attention, with urgency determined by the person's circumstances and level of risk. Immediate danger, recent serious self-harm, acute psychosis, a possible manic episode with major behavioural change, severe agitation or inability to maintain safety may require urgent or emergency care. Sudden confusion or marked behavioural change may also reflect a medical, neurological or substance-related problem rather than a primary mental disorder.

WHO's current suicide guidance emphasizes timely support, assessment and care, and emergency action where there is immediate danger.[8] WHO's current mental disorder guidance also confirms that effective treatment options exist for conditions including depression, bipolar disorder and schizophrenia.

In Viet Nam, this boundary also has a legal dimension. Medical examination and treatment remain regulated professional activities under the Law on Medical Examination and Treatment No. 15/2023/QH15, effective from 1 January 2024, and its implementing regulations, including Decree No. 96/2023/ND-CP.[16,17]

Participation in a social prescribing pathway does not authorize a community organization, volunteer or link worker to diagnose a mental disorder, prescribe or change medication, or undertake regulated clinical treatment unless they are otherwise legally qualified and authorized to do so.

Social prescribing may still become relevant after or alongside clinical care. Someone recovering after a mental health crisis may need help to reconnect with study, employment, exercise, friendships or meaningful community roles. The community connection can support recovery, but it should complement rather than displace the care and monitoring the person requires.

Community organizations need clear roles, particularly for more complex mental health needs

Most community organizations are not mental health services, and referral through social prescribing should not turn them into mental health services.

A volunteer running an art group may notice that someone appears distressed. They can respond with humanity, listen appropriately, recognize warning signs they have been trained to recognize and follow an agreed escalation pathway. They should not be expected to conduct a clinical psychiatric assessment or make clinical risk-management decisions unless they are appropriately qualified and authorized.

A sports coach can provide encouragement and connection but should not decide whether someone should stop antidepressant medication. A community group can provide belonging but should not become the sole response when someone's symptoms require professional treatment.

This does not mean community organizations should exclude people simply because they live with a mental disorder. Social exclusion itself can damage recovery and well-being. The issue is role clarity, not diagnosis.

Before routinely receiving mental health-related referrals, a community resource should understand which needs it can reasonably support, who is responsible for the activity, how concerns should be escalated, what to do when an urgent safety issue arises and what information is genuinely necessary. Staff and volunteers may also need proportionate training and access to appropriate support depending on the population and activity.

The organization should be able to say when a person's needs exceed what it can safely provide or when its own capacity has been reached.

Particular care is needed when developing pathways involving people with severe or enduring mental health conditions. Social inclusion, education, employment, physical activity, friendships and meaningful roles can be extremely important to recovery, but the evidence for social prescribing in this population remains less developed.

A 2025 UK rapid review of 53 articles identified limited representation of people with severe mental illness in the existing literature and added a second search specifically because of that gap. The review itself did not formally quality-appraise included papers, and its authors noted that causal evidence was limited, so its findings should be interpreted cautiously.[10]

The September 2026 umbrella review similarly found the evidence among people with diagnosed mental disorders less robust than the evidence from general populations.[3] This suggests that pathways involving psychosis, bipolar disorder or other complex mental health needs should maintain closer relationships with mental health services rather than assume that the same community referral model will be appropriate for everyone.

The aim should still be inclusion rather than unnecessary medicalization. A person with schizophrenia should be able to participate in ordinary community life like anyone else. What may differ is the level of coordination, continuity and support required when their clinical needs change.

What does this mean for Viet Nam?

Viet Nam is strengthening grassroots healthcare while also developing social care and rehabilitation services. This creates an important context for thinking about how community connection might complement mental healthcare, but there is currently far too little Vietnamese social prescribing research to claim that social prescribing has been shown to improve mental health outcomes here.

WHO Viet Nam states that it is supporting the integration of mental health into general health services, with particular attention to primary healthcare.[11] This aligns with broader WHO guidance calling for accessible, rights-based community mental health networks rather than reliance solely on specialist or institutional services.

There is also an important development in Viet Nam's current policy landscape. Circular No. 34/2026/TT-BYT, issued and effective on 8 September 2026, guides implementation of components of the National Target Programme on Health Care, Population and Development for 2026–2035.[12]

Among its social care provisions, the Circular provides for investment in facilities involved in care and rehabilitation for people with mental health-related needs and introduces a pilot semi-residential care model at social work centres and social assistance facilities. The model includes specified groups such as people with mental health disturbances, depression and autism and can include needs assessment, case management, rehabilitation planning, intervention, therapy, counselling, healthcare and support for community inclusion.[12]

This is relevant because it shows that mental health-related social care, rehabilitation and community-linked support are increasingly visible within Viet Nam's evolving policy landscape. These formal services should not, however, be relabeled as social prescribing.

A social prescribing pathway would have a more specific connecting function. It might help someone reach an ordinary physical activity group, creative or cultural activity, volunteering opportunity, learning program, community organization or other non-clinical source of participation when that resource is appropriate to what matters to them.

If the person's need is counselling, clinical treatment, formal rehabilitation or social work, the pathway should help them reach the appropriate professional service under its proper role rather than treating every destination as social prescribing.

This requires avoiding two opposite errors. One is failing to recognize clinical need. A person experiencing serious depression, psychosis, mania or significant suicide risk may be directed toward ordinary community support when professional assessment and treatment are required. Community connection may still help, but it is not sufficient by itself.

The other is over-medicalization of distress. Bereavement, loneliness, life transitions and social stress should not automatically be treated as psychiatric disorders when someone's primary need may be human connection, practical support or an opportunity to participate meaningfully in community life.

A mature pathway needs to distinguish these situations while also recognizing that they can overlap. Healthcare, mental health services, social work, rehabilitation and community organizations should retain their own responsibilities while being able to connect people across those boundaries when needs change.

Mental health information requires particular care

Mental health-related pathways may involve highly sensitive information, and community organizations do not automatically need a person's complete psychiatric or medical history simply because the connection originated in healthcare.

For many ordinary community activities, only limited information may be required, such as the person's name and contact details, their interest in participating and information genuinely necessary for safe and appropriate access.

Viet Nam's Law on Personal Data Protection No. 91/2025/QH15 and Decree No. 356/2025/ND-CP have both been in effect since 1 January 2026.[13,14] Decree 356 lists health status among sensitive personal data, and Article 26 of the Law specifically provides that the collection and processing of personal data relating to health require the data subject's consent except in the circumstances specified in Article 19(1), alongside compliance with other applicable requirements.[13,14]

Organizations developing a structured social prescribing pathway therefore need to identify what information is necessary, why it is being processed, the applicable legal basis and, for health information, the relevant consent requirements and statutory exceptions. They should also define who can access the information and how it will be protected.

This is especially important in mental health because unnecessary disclosure can expose people to stigma, discrimination or loss of trust.

The practical principle is straightforward: share what the receiving organization genuinely needs for its role, not everything that is known about the person.

What could an early Vietnamese pathway test?

Mental health is not an area in which Viet Nam should build a large referral network first and decide the governance later. Early work would be safer and more informative if it begins on a limited scale with clearly defined roles, referral criteria, information-sharing arrangements and escalation pathways.

One possible starting point would be people whose principal needs involve social isolation, loss of meaningful activity, low confidence, caregiving pressure or another psychosocial issue, including some people who are already receiving mental healthcare and are clinically able to participate in ordinary community activities.

The linking conversation should begin with the person's priorities rather than their diagnosis. Someone living with depression might value physical activity, but another person may prefer volunteering, art, learning or practical employment support. Someone recovering from psychosis may want to return to study rather than be referred automatically to a group labelled for “mental health.”

Clinical services and community partners should agree in advance what happens when concerns arise. Where appropriate, the pathway should provide access to a clear professional contact or escalation route, realistic expectations about community roles and proportionate information sharing.

Evaluation should distinguish between different outcomes. Did the person actually connect with the resource? Did they participate? Did they feel more confident, supported or socially connected? Did depressive or anxiety symptoms change where those were relevant outcomes? Did quality of life improve? Was necessary clinical care maintained? Were there inappropriate referrals, stigma, deterioration or other unintended consequences? How did community partners experience receiving referrals?

These questions are important because harms remain poorly reported in the social prescribing literature. A 2026 global umbrella review identified plausible psychological, group or social, equity and opportunity harms, while emphasizing that better research is needed to establish how often such harms actually occur.[15]

People with lived experience of mental health difficulties should also be involved in designing, evaluating and improving any pathway. WHO's 2025 policy guidance explicitly emphasizes meaningful participation of people with lived experience and cross-sector collaboration in mental health system development.[7]

Key Takeaway

Mental health is shaped by psychological, biological, social and structural factors. That makes community support relevant, but it does not make community support a substitute for mental healthcare.

Social prescribing may add value by helping some people rebuild relationships, routines, confidence, physical activity, meaningful roles and participation. It may also complement treatment for people living with mental disorders by addressing aspects of recovery and everyday life that clinical care alone may not provide.

The evidence is promising but not definitive. Observational and qualitative research frequently reports improvements in well-being, belonging and purpose, while randomized evidence suggests modest benefits for some outcomes, including depressive symptoms, but no clear effect for several others. Evidence among people with more severe mental disorders remains particularly limited.

For Viet Nam, social prescribing should therefore not be framed as replacing any part of mental healthcare. Its potential contribution is more specific: helping people reach meaningful, appropriate non-clinical community resources when those connections can add value to well-being or recovery, while ensuring that professional care remains available whenever symptoms, safety or treatment needs require it.

The most useful question is not simply whether community support “works for mental health.” It is:

“Where can a community connection add something meaningful to a person's recovery or well-being, while ensuring that clinical care remains central whenever it is needed?”

The strongest model will not be the one that sends the largest number of people from healthcare into the community. It will be the one that knows when community life can help, when professional care is essential, and how the two can work together without confusing their roles.

References
  1. World Health Organization. Mental health. 11 September 2026.

  2. World Health Organization. Mental disorders. 11 September 2026.

  3. Guerouaou F, Maillard A, Franck N, et al. Mental health benefits of social prescribing in the general population and among people with mental disorders: an umbrella review. International Journal of Mental Health Systems. Published online 18 September 2026. doi:10.1186/s13033-026-00735-8.

  4. Spanos S, Wijekulasuriya S, Ellis LA, Saba M, Schroeder T, Officer C, Zurynski Y. Integrating Non-Clinical Supports into Care: A Systematic Review of Social Prescribing Referral Pathways for Mental Health, Wellbeing, and Psychosocial Improvement. International Journal of Integrated Care. 2025;25(3):21. doi:10.5334/ijic.9127.

  5. Feng X, Kanukula R, Evangelidis N, et al. Effects of social prescribing on mental, physical, and social health outcomes: a systematic review and meta-analysis of randomised trials. medRxiv. Posted 3 August 2026. doi:10.64898/2026.08.02.26359484. Preprint, not yet peer reviewed.

  6. World Health Organization. Guidance on community mental health services: promoting person-centred and rights-based approaches. Geneva: World Health Organization; 2021.

  7. World Health Organization. Guidance on mental health policy and strategic action plans. Geneva: World Health Organization; 2025.

  8. World Health Organization. Suicide. Questions and Answers. Updated 31 August 2026.

  9. World Health Organization. Mental Health Gap Action Programme guideline for mental, neurological and substance use disorders. 3rd ed. Geneva: World Health Organization; 2023.

  10. Edwards-Smith A, Ajiboye A, Pywell S, Kenyon A, Routh F, Williams J. Adult Mental Health, Major Conditions and Social Prescribing: A Rapid Review. Health & Social Care in the Community. 2025;2025:2917260. doi:10.1155/hsc/2917260.

  11. World Health Organization Viet Nam. Mental health in Viet Nam. WHO Viet Nam. Accessed 25 September 2026.

  12. Ministry of Health of Viet Nam. Circular No. 34/2026/TT-BYT guiding selected contents of the National Target Programme on Health Care, Population and Development 2026–2035, Phase I: 2026–2030. 8 September 2026. Effective 8 September 2026.

  13. National Assembly of the Socialist Republic of Viet Nam. Law on Personal Data Protection No. 91/2025/QH15. 26 June 2025. Effective 1 January 2026.

  14. Government of Viet Nam. Decree No. 356/2025/ND-CP detailing certain provisions and measures for implementation of the Law on Personal Data Protection. 31 December 2025. Effective 1 January 2026.

  15. Cooper M, Okeowo D, Bennett L, et al. Potential harms of social prescribing: a global umbrella review and dark logic model. BMJ Open. 2026;16(5):e108998. doi:10.1136/bmjopen-2025-108998.

  16. National Assembly of the Socialist Republic of Viet Nam. Law on Medical Examination and Treatment No. 15/2023/QH15. 9 January 2023. Effective 1 January 2024.

  17. Government of Viet Nam. Decree No. 96/2023/ND-CP detailing certain provisions of the Law on Medical Examination and Treatment. 30 December 2023. Effective 1 January 2024.

Article Information

Published: 25 September 2026
Last reviewed: 25 September 2026
Publisher: Social Prescribing Vietnam

Disclaimer

This article is provided for educational and informational purposes. It does not constitute medical advice, mental health assessment, diagnosis, treatment, clinical guidance, crisis advice, legal advice or official policy. Mental health needs and levels of risk vary considerably between individuals. Social prescribing should not be used as a substitute for appropriate medical, psychological, psychiatric, social work or other professional assessment and care when these are required. A person experiencing an immediate risk of self-harm, suicide or serious harm requires urgent professional or emergency assistance. Organizations developing social prescribing pathways should determine the applicable Vietnamese legal, professional, safety, information-sharing and personal data protection requirements for their specific activities.